stars 1 stars 2 stars 3

We are now Fortrea. To keep updated on the latest news from Fortrea, please visit our LinkedIn page at https://www.linkedin.com/company/fortrea Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.

Website http://www.fortrea.com/
Revenue $5.9 million
Employees 269 (140 on RocketReach)
Founded 1982
Industry Hospitals and Health Care, Clinical Trials, Biopharma, Clinical Analytics, Medical Device and Diagnostics, Source (FSP/Resourcing), Oncology, Ophthalmology, Respiratory, Anti-infectives/Vaccines, Dermatology, Data Management, Eclinical, Biostatistics, SAS Programming, Clinical Monitoring
Web Rank 6 Million
Keywords Clinical Development, Clinical Operations, Patient Access Solutions, Regulatory Affairs, Clinical Research, Medical Affairs, Pharmaceutical Services, Pharmacovigilance, Drug Development, Drug Safety, Clinical Trials, Healthcare Consulting, Healthcare Solutions, Clinical Monitoring, Biopharmaceutical Services, Data Management, Medical Research, Global Healthcare, Life Sciences
Competitors Synchrony Financial, Covance, Syneos Health, ICON plc, Charles River Laboratories, PPD, Medpace, Worldwide Clinical Trials, Research Pharmaceutical Services, IQVIA +36 more (view full list)

Theorem (now Chiltern) Questions

The Theorem (now Chiltern) annual revenue was $5.9 million in 2026.

Mary Spadola is the Training Director of Theorem (now Chiltern).

140 people are employed at Theorem (now Chiltern).

Top Theorem (now Chiltern) Employees

View Similar People
Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Spring 2026 G2 Best Est ROI Mid Market Spring 2026 G2 Easiest Admin Mid Market Spring 2026 G2 Most Implementable Spring 2026 G2 Best Results Mid Market Spring 2026 G2 Lead Capture Mid Market Spring 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2025
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users